Tue, March 14, 2023

Paul Knight Upgraded (CDMO) to Buy and Held Target at $20 on, Mar 14th, 2023

Paul Knight of Keybanc, Upgraded "Avid Bioservices, Inc." (CDMO) to Buy and Held Target at $20 on, Mar 14th, 2023.

Paul, nor any peers, have made any analyst calls on CDMO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30